Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma: Three case reports

RATIONALE: Refractory nasopharyngeal carcinoma is challenging to treat and at present there is no standard treatment or any good choice. PATIENT CONCERNS: Although the three patients in our case reports had already underwent multiple treatments before, they still suffered from disease recurrence of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Chen, Chen, Liu, Song-Ran, Zhou, Shu, Li, Xiao-Hui, Wang, Xiao-Hui, Tao, Ya-Lan, Chang, Hui, Zhang, Wen-Wen, Li, Wen-Fei, Zhou, Si-Lang, Xia, Yun-Fei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6709293/
https://ncbi.nlm.nih.gov/pubmed/31393358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016592
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak